Relationship between albumin-globulin ratio and prostate-specific antigen: a cross-sectional study based on NHANES 2003–2010

Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. Methods This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and...

Full description

Saved in:
Bibliographic Details
Published inBMC urology Vol. 25; no. 1; pp. 3 - 8
Main Authors Gao, Simeng, Li, Shaojie, Wu, Baofang, Wang, Jiayin, Ding, Sijuan, Tang, Zhaohui
Format Journal Article
LanguageEnglish
Published London BioMed Central 07.01.2025
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1471-2490
1471-2490
DOI10.1186/s12894-024-01687-2

Cover

Abstract Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. Methods This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. Results This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an “L”-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. Conclusion In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32. Clinical trial number Not applicable.
AbstractList Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. Methods This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. Results This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an "L"-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. Conclusion In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32. Clinical trial number Not applicable. Keywords: Albumin-globulin ratio, Prostate-specific antigen, NHANES, Cross-sectional study
The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an "L"-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32. Not applicable.
The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an "L"-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32.
Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. Methods This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. Results This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an “L”-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. Conclusion In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32. Clinical trial number Not applicable.
PurposeThe albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported.MethodsThis cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests.ResultsThis study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an “L”-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA.ConclusionIn the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32.Clinical trial numberNot applicable.
The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported.PURPOSEThe albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported.This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests.METHODSThis cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests.This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an "L"-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA.RESULTSThis study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an "L"-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA.In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32.CONCLUSIONIn the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32.Not applicable.CLINICAL TRIAL NUMBERNot applicable.
Abstract Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has not been reported. Methods This cross-sectional investigation used comprehensive AGR versus PSA data from men with 40 years of age and older, who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 to 2010, spanning 4 investigation cycles, as only these cycles contained complete PSA data. To evaluate the nonlinear relationship between the ARG and PSA level, a regression utilizing smoothed curve fitting (penalized spline approach) and a generalized additive model (GAM) were employed. A two-segment linear regression model was used to conduct threshold effect evaluations. Lastly, subgroup analyses were carried out along with interaction tests. Results This study included 5,376 subjects, whose total serum PSA (mean ± standard deviation) was 1.83 ± 3.34, and its level decreased roughly with increasing quartiles of AGR. In the fully-adjusted model, AGR was negatively correlated with the likelihood of PSA, and this relationship persisted across subgroups (trend > 0.05). The PSA was characterized by an “L”-shaped curve with an inflection point. On the left side of the inflection point (K = 1.32), there was a negative relationship between AGR and PSA. Conclusion In the United States, among men over 40 years of age without prostate diseases, AGR demonstrated a nonlinear relationship with PSA, negatively correlating when AGR was below 1.32. Clinical trial number Not applicable.
ArticleNumber 3
Audience Academic
Author Ding, Sijuan
Gao, Simeng
Wu, Baofang
Tang, Zhaohui
Wang, Jiayin
Li, Shaojie
Author_xml – sequence: 1
  givenname: Simeng
  surname: Gao
  fullname: Gao, Simeng
  organization: The Central Hospital of Yongzhou
– sequence: 2
  givenname: Shaojie
  surname: Li
  fullname: Li, Shaojie
  organization: The Second Affiliated Hospital of Fujian Medical University
– sequence: 3
  givenname: Baofang
  surname: Wu
  fullname: Wu, Baofang
  organization: The Second Affiliated Hospital of Fujian Medical University
– sequence: 4
  givenname: Jiayin
  surname: Wang
  fullname: Wang, Jiayin
  organization: The Second Affiliated Hospital of Fujian Medical University
– sequence: 5
  givenname: Sijuan
  surname: Ding
  fullname: Ding, Sijuan
  organization: The Central Hospital of Yongzhou
– sequence: 6
  givenname: Zhaohui
  surname: Tang
  fullname: Tang, Zhaohui
  email: tangzhaohui2023@163.com
  organization: The Central Hospital of Yongzhou
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39762822$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAUhiNURC_wAiyQJTZsUnyJHYcNGlWFVqqKxGVt2c5J6lHGHuykqBvEO_CGPAnOTGk7CCHLsnX8nd_n2P9hseeDh6J4TvAxIVK8ToTKpioxzZMIWZf0UXFAqpqUtGrw3oP9fnGY0hJjUksunhT7rKkFlZQeFN8_wqBHF3y6cmtkYPwG4JEezLRyvuyHYKbBeRRnBmnfonUMadQjlGkN1nXO5ujoevBvkEY2H6YygZ0V9YDSOLU3yOgELQoeXZ4tLk8_IYox-_XjJ8UEPy0ed3pI8Ox2PSq-vDv9fHJWXnx4f36yuCgt581Y1o1mraCE2Y40lNQNxZVp21o00gguwdoK2w5TsK3lotPACeGECks45S3n7Kg43-q2QS_VOrqVjjcqaKc2gRB7pePo7ADK0IoJMLXhoq6IENJSYHWDTcOBm4plrbdbrfVkVtBa8GPUw47o7ol3V6oP14qQGgssSVZ4dasQw9cJ0qhWLlkYBu0hTEkxwpkUgrG58Jd_ocswxfy2G4qKRnBM7qle5w6c70K-2M6iapG_mctK8rnw439QebSwcjZ7q3M5vpPw4mGndy3-sU8G6BbYfHyE7g4hWM0eVVuPquxRtfGompPYNill2PcQ71v6T9ZvgKTm_g
Cites_doi 10.1186/s12944-020-01234-6
10.1007/s11845-023-03431-5
10.1097/01.ju.0000169255.64518.fb
10.1155/2015/145647
10.1001/jamaoncol.2021.5143
10.3390/nu15153298
10.1186/s12885-017-3814-3
10.1038/s41598-023-43391-5
10.3322/caac.21660
10.1186/s12890-023-02574-6
10.1055/s-0042-108071
10.3389/fnut.2022.1012181
10.3389/fpubh.2023.1078280
10.4062/biomolther.2023.132
10.1186/1475-2891-9-69
10.1080/03007995.2018.1479683
10.1056/NEJM199902113400607
10.1111/aor.12557
10.3390/ijms231911501
10.1007/s10147-021-01952-6
10.1016/j.amjsurg.2013.03.007
10.4111/icu.20210105
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12894-024-01687-2
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central Database Suite (ProQuest)
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ: Directory of Open Access Journal (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE


Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2490
EndPage 8
ExternalDocumentID oai_doaj_org_article_b2436eb7b56741668c2e3790b95e5b43
PMC11706081
A822584853
39762822
10_1186_s12894_024_01687_2
Genre Journal Article
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QP
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c559t-79a3d6213cf192179204bdd7698b658ecc40cf02ecdc56fae5115126c1525d553
IEDL.DBID M48
ISSN 1471-2490
IngestDate Wed Aug 27 01:30:17 EDT 2025
Thu Aug 21 18:34:47 EDT 2025
Fri Sep 05 02:57:19 EDT 2025
Fri Jul 25 22:44:24 EDT 2025
Tue Jun 17 21:57:30 EDT 2025
Tue Jun 10 20:53:53 EDT 2025
Wed Feb 19 02:02:12 EST 2025
Tue Jul 01 01:02:49 EDT 2025
Sat Sep 06 07:22:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords NHANES
Cross-sectional study
Albumin-globulin ratio
Prostate-specific antigen
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c559t-79a3d6213cf192179204bdd7698b658ecc40cf02ecdc56fae5115126c1525d553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12894-024-01687-2
PMID 39762822
PQID 3152696501
PQPubID 42551
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_b2436eb7b56741668c2e3790b95e5b43
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11706081
proquest_miscellaneous_3153866335
proquest_journals_3152696501
gale_infotracmisc_A822584853
gale_infotracacademiconefile_A822584853
pubmed_primary_39762822
crossref_primary_10_1186_s12894_024_01687_2
springer_journals_10_1186_s12894_024_01687_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-01-07
PublicationDateYYYYMMDD 2025-01-07
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-07
  day: 07
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC urology
PublicationTitleAbbrev BMC Urol
PublicationTitleAlternate BMC Urol
PublicationYear 2025
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References E-S Kim (1687_CR23) 2023; 31
BN Azab (1687_CR19) 2013; 206
K Xu (1687_CR8) 2023; 11
C Gabay (1687_CR21) 1999; 340
RD Etzioni (1687_CR4) 2005; 174
H Sung (1687_CR1) 2021; 71
M Zhang (1687_CR3) 2023
Z Xia (1687_CR5) 2022; 9
D Gupta (1687_CR10) 2010; 9
A Aydh (1687_CR12) 2021; 26
S Salciccia (1687_CR13) 2022; 23
J-W Chung (1687_CR11) 2021; 62
SB Asegaonkar (1687_CR22) 2015; 2015
J Li (1687_CR16) 2023; 13
EJ Meyer (1687_CR6) 2016; 48
J Song (1687_CR9) 2020; 19
MS Leapman (1687_CR2) 2022; 8
S Ikeda (1687_CR15) 2017; 17
Y Bozkaya (1687_CR17) 2019; 35
C Pfensig (1687_CR20) 2016; 40
J Chen (1687_CR18) 2023; 23
Q Li (1687_CR14) 2015; 5
H-Y Lin (1687_CR7) 2023; 15
References_xml – volume: 19
  start-page: 82
  year: 2020
  ident: 1687_CR9
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-020-01234-6
– year: 2023
  ident: 1687_CR3
  publication-title: Ir J Med Sci
  doi: 10.1007/s11845-023-03431-5
– volume: 174
  start-page: 877
  year: 2005
  ident: 1687_CR4
  publication-title: J Urol
  doi: 10.1097/01.ju.0000169255.64518.fb
– volume: 5
  start-page: 2856
  year: 2015
  ident: 1687_CR14
  publication-title: Am J Cancer Res
– volume: 2015
  start-page: 145647
  year: 2015
  ident: 1687_CR22
  publication-title: Int J Breast Cancer
  doi: 10.1155/2015/145647
– volume: 8
  start-page: 41
  year: 2022
  ident: 1687_CR2
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2021.5143
– volume: 15
  start-page: 3298
  year: 2023
  ident: 1687_CR7
  publication-title: Nutrients
  doi: 10.3390/nu15153298
– volume: 17
  start-page: 797
  year: 2017
  ident: 1687_CR15
  publication-title: BMC Cancer
  doi: 10.1186/s12885-017-3814-3
– volume: 13
  start-page: 17272
  year: 2023
  ident: 1687_CR16
  publication-title: Sci Rep
  doi: 10.1038/s41598-023-43391-5
– volume: 71
  start-page: 209
  year: 2021
  ident: 1687_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 23
  start-page: 275
  year: 2023
  ident: 1687_CR18
  publication-title: BMC Pulm Med
  doi: 10.1186/s12890-023-02574-6
– volume: 48
  start-page: 359
  year: 2016
  ident: 1687_CR6
  publication-title: Horm Metab Res
  doi: 10.1055/s-0042-108071
– volume: 9
  start-page: 1012181
  year: 2022
  ident: 1687_CR5
  publication-title: Front Nutr
  doi: 10.3389/fnut.2022.1012181
– volume: 11
  start-page: 1078280
  year: 2023
  ident: 1687_CR8
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2023.1078280
– volume: 31
  start-page: 473
  year: 2023
  ident: 1687_CR23
  publication-title: Biomol Ther (Seoul)
  doi: 10.4062/biomolther.2023.132
– volume: 9
  start-page: 69
  year: 2010
  ident: 1687_CR10
  publication-title: Nutr J
  doi: 10.1186/1475-2891-9-69
– volume: 35
  start-page: 275
  year: 2019
  ident: 1687_CR17
  publication-title: Curr Med Res Opin
  doi: 10.1080/03007995.2018.1479683
– volume: 340
  start-page: 448
  year: 1999
  ident: 1687_CR21
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199902113400607
– volume: 40
  start-page: 397
  year: 2016
  ident: 1687_CR20
  publication-title: Artif Organs
  doi: 10.1111/aor.12557
– volume: 23
  start-page: 11501
  year: 2022
  ident: 1687_CR13
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms231911501
– volume: 26
  start-page: 1729
  year: 2021
  ident: 1687_CR12
  publication-title: Int J Clin Oncol
  doi: 10.1007/s10147-021-01952-6
– volume: 206
  start-page: 764
  year: 2013
  ident: 1687_CR19
  publication-title: Am J Surg
  doi: 10.1016/j.amjsurg.2013.03.007
– volume: 62
  start-page: 545
  year: 2021
  ident: 1687_CR11
  publication-title: Investig Clin Urol
  doi: 10.4111/icu.20210105
SSID ssj0017856
Score 2.345722
Snippet Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen...
The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen (PSA) has...
Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen...
PurposeThe albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific antigen...
Abstract Purpose The albumin-globulin ratio (AGR) influences the development of prostate cancer; however, the relationship between AGR and prostate-specific...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 3
SubjectTerms Adult
Age
Aged
Albumin
Albumin-globulin ratio
Alcohol
Analysis
Angina pectoris
Antigens
Body mass index
Cardiovascular disease
Chronic illnesses
Coronary vessels
Creatinine
Cross-Sectional Studies
Cross-sectional study
Dehydrogenases
Diabetes
Globulins
Humans
Hypertension
Internal Medicine
Laboratories
Male
Medical prognosis
Medicine
Medicine & Public Health
Metastasis
Middle Aged
NHANES
Nitrogen
Nutrition Surveys
Prostate cancer
Prostate-specific antigen
Prostate-Specific Antigen - blood
Prostatic Neoplasms - blood
Prostatic Neoplasms - epidemiology
Proteins
Regression analysis
Serum Albumin - analysis
Serum Globulins - analysis
Surveys
Triglycerides
Uric acid
Urology
Variables
Vein & artery diseases
SummonAdditionalLinks – databaseName: DOAJ: Directory of Open Access Journal (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLVQFxUbBOUV2iIjIbGAqI4dP8JuQK1GSJ0NVOrO8ivqbDIjZrpF_EP_kC_hXieZNkWIDdvYUWzfe-Nj-_hcQt4y07ZVgEVOy8EMdcur0qlalypoFhPzSeV0b-cLNb-ov1zKyzupvpAT1ssD9wN34nktVPLaS4XgQZnAk9AN841M0tdZ55M1bFxMDecH2kg1XpEx6mQDf2GUwOXIuFAQVnwyDWW1_j__yXcmpfuEyXunpnkyOntMHg0oks761j8hD1J3QPbPh3Pyp-THjuN2tVzTgYtFMxV52ZUoAoIEdJqtT10X6RovfwDsLPHmJbKH4OkWhTo_UkdzF8pNJm3hZ7MkLcX5L9JVRxfz2eL0K0X-2a-fN3ju_YxcnJ1--zwvh0wLZYAVxbbUjRNR8UqEFvXRdMNZ7WPUqjEeIAqYuWahZTyFGKRqXQKYBkhBBcyeFKUUz8let-rSS0K1TqqKsOxKuKOkHFjORR6EE96EVLUFeT8OvF33gho2L0SMsr2ZLJjJZjNZXpBPaJtdTRTDzg_ARezgIvZfLlKQd2hZiyEL5gtuuHkADUbxKzsDkAQ4DIBLQY4mNSHUwrR49A07hPrGigqTtAPQrQryZleMbyJ9rUur61xHGMB2QhbkRe9Kuy4hIEQub0HMxMkmfZ6WdMurLAReZe0jAx_-MPrjbbv-Pqiv_segHpKHHFMh426UPiJ72-_X6Rjw2da_zqH4G1AANCI
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BkRAXVD6btiAjIXGAqImd2NleqgW1WiF1L1Bpb1b8EbqXZOlur4j_0H_IL2HG66SkCK5xItuZGfvZfn4D8Darmia3uMhpOJqhaHie1rJQqbQqcz4zXoZ0b-dzObsoPi_KRdxwW0daZT8mhoHadZb2yI9ETrmwEU_kJ6vvKWWNotPVmELjPjwI0mXoz2oxLLgo8bzsL8pU8miNYzEJ4XLiXUgMLj6ajIJm_98j8x9T013a5J2z0zAlne3C44gl2XRr_Cdwz7dP4eF5PC1_Bj8GptvlcsUiI4sFQvKyTUkKhGjoLPgAq1vHVnQFBMFnSvcviUOETzck13nMaha6kK4DdYuqDcK0jGZBx7qWzWfT-ekXRiy0Xz9v6PT7OVycnX79NEtjvoXU4rpik6pJLZzkubANqaSpCc8K45ySk8ogUEFjF5ltMu6ts6Vsao9gDfGCtJRDyZWleAE7bdf6PWBKeZk7XHx52leStVGmdtyKWpjK-rxJ4H3_4_VqK6uhw3KkknprJo1m0sFMmifwkWwzvEmS2OFBd_VNxwjThhdCeqyolIQyZWW5F2qSGWxEaQqRwDuyrKbARfPZOt4_wAaTBJaeIlRCNIbwJYHD0ZsYcHZc3PuGjgG_1rfumcCboZi-JBJb67vr8I6oEOGJMoGXW1caukSwkBi9CVQjJxv1eVzSLi-DHHgeFJAqrPhD74-37fr3T93_fzcO4BGnVMe026QOYWdzde1fIf7amNchyH4D7AUsjg
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwELVQkRAXVL5TCjISEgeIiO147O1tqVqtkLoXqNSbFX9E3Ut21d1eEf-Bf8gvYcabTZsCB66xI9sZj_2ceX7D2LvKtq0IeMhpJZqhbqUoG6hNCcFUMVU-QU73djaH2Xn95UJf9DI5dBfmdvxeWPi0xvWTxGslcSUAHQKX2_taKMiBWTgeIgbGathdivnre6ONJ-vz_7kK39qG7lIk78RJ8_Zzus8e9biRT7eGfszupe4Je3DWR8afsu8Dq-1yseI9-4pn8vGiK0n2gyjnPNubN13kK7rugUCzpLuWxBfCpxuS5jziDc9DKNeZpkXNZhFaTjte5MuOz2fT-clXToyzXz9-UqT7GTs_Pfl2PCv73AplwDPEpjSTRkWQQoWWFNHMRFa1j9HAxHoEJWjYugptJVOIQUPbJARmiA0gUL6kqLV6zva6ZZdeMm5MAhHxoJXoHxI03vgmyqAa5W1Ioi3Yh92Hd6uthIbLRw8Lbmsmh2Zy2UxOFuwz2WaoSfLX-QHOCtd7k_OyVpCwIQ2EKMEGmZSZVB47oX2tCvaeLOvISdF8oenvGmCHSe7KTREWIfJCqFKww1FNdK4wLt7NDdc799opQWnZEdqKgr0diulNIqx1aXmd6yiLaE7pgr3YTqVhSAQBib1bMDuaZKMxj0u6xWWW_hZZ7chiwx938_GmX__-qAf_V_0VeygpzTH9aTKHbG9zdZ1eI_ba-DfZ6X4DtOMlgg
  priority: 102
  providerName: Springer Nature
Title Relationship between albumin-globulin ratio and prostate-specific antigen: a cross-sectional study based on NHANES 2003–2010
URI https://link.springer.com/article/10.1186/s12894-024-01687-2
https://www.ncbi.nlm.nih.gov/pubmed/39762822
https://www.proquest.com/docview/3152696501
https://www.proquest.com/docview/3153866335
https://pubmed.ncbi.nlm.nih.gov/PMC11706081
https://doaj.org/article/b2436eb7b56741668c2e3790b95e5b43
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fi9NAEB_OOzjuRfxv9CwrCD5oNNlNdlNBpC09itAip4Xiy5LsbryCpLXtgb6I38Fv6CdxZpv0zHm--BJIdsP-mZmdmd3Z3wA8ibKyjA06OSVHMiQlj8NcJiqURkXWRYWTPt3beCJH0-TtLJ3tQZPuqJ7A9ZWuHeWTmq4-v_j65dsbFPjXXuAz-XKNaywB3HKKp5AoNLgkH6BmkuSMjZOLUwWVpbK5OHPlf0dwSPqZQitbesrD-f-9aP-htS5HVF46VvXa6uQGXK_NTNbb8sVN2HPVLTgc1wfpt-H7LgjubL5kdbAW87HK8yoklBCKUGeePVheWbak2yFol4Z0NZPCi_DrhpA8X7Gc-SGEax_VRc16zFpGCtKyRcUmo95k-J5RgNqvHz_pYPwOTE-GHwajsE7FEBp0OTah6ubCSh4LUxKAmuryKCmsVbKbFWjDIB8kkSkj7ow1qSxzh3YcmhLSUHolm6biLuxXi8rdB6aUk7FFv8zRlpPMC1XklhuRiyIzLi4DeNZMvF5uETe091QyqbcU00gx7SmmeQB9os2uJqFl-w-L1SddC58ueCKkw4ZSSQaozAx3QnWjAjuRFokI4ClRVhOXIflMXl9NwA4TOpbuIT-goYaWTQDHrZooi6Zd3PCGblhZi5iyuKMlHAfweFdMf1J8W-UW576OyND4E2kA97astBtSw5EBZC0ma425XVLNzzxSeOzBkTJs-HnDjxf9-vekPvj_lh7CEacMybRJpY5hf7M6d4_QbNsUHbimZqoDB_3h5N0pvg3koOO3QDpeSvF52v_4G4GNQrM
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB5VWwm4IP4JFDASiANETZzEziIhtIWttrS7QtBKvbmJ7dC9JEt3K8QF8Q68Bw_FkzDj_JQUwa3XOJHtzIzns_3NDMCTIC2KUOMmp-AohrjgoZ-JWPpCy8DYILfClXubzsTkIH53mByuwc82FoZole2a6BZqU2k6I9-MQqqFjXgifL347FPVKLpdbUto1Gqxa79-wS3b8tXOW5TvU863x_tvJn5TVcDXiJ5XvhxmkRE8jHRBucDkkAdxbowUwzRHd4xTigNdBNxqoxNRZBYhCXpFoalSkEmoSgQu-esxRbQOYH1rPHv_obu3kGki2tCcVGwucfWn1LucmB4CzZn33J-rEvC3L_jDGZ4nap67rXVOcPsaXG3QKxvV6nYd1mx5Ay5Nm_v5m_Ct49Ydzxes4YAxR4Gelz4lHyHiO3Nax7LSsAUFnSDc9Snik1hL-HRFCUJfsoy5KfhLRxajbl0qXEZ-17CqZLPJaDb-yIj39uv7D7pvvwUHFyKL2zAoq9LeBSalFaHB7Z6lkyyR5TLPDNdRFuWptmHhwfP2x6tFnchDuQ1QKlQtJoViUk5MinuwRbLp3qQk3O5BdfJJNTatch5HwmJHiSBcK1LNbSSHQY6DSPI48uAZSVbRUoHi01kT8YADpqRbaoTgDPEfAiYPNnpvoonrfnOrG6pZYpbqzCA8eNw105dEmyttdereiVLElFHiwZ1albopERAlDrEHaU_JenPut5TzY5eAPHQ5l1Ls-EWrj2fj-vdPvff_aTyCy5P96Z7a25nt3ocrnAot01mX3IDB6uTUPkD0t8ofNibH4Oiirfw38K5p5w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6hIlVcEG8CBYyExAGiJnZie7ktpavl0RUSVOrNih9p95JddbdXxH_gH_JLmHEeNAUOXGNHtjMe-3Pmm88ALzJd17nDQ07N0QxFzfO0koVKpVOZD5kNMl73drSQ8-Piw0l5cimLP7Ld-5Bkm9NAKk3Ndn_t69bFtdzf4KpKkracGBQS3QQX4esFbX0UrpUHQxxB6VL2qTJ_fW-0HUXV_j_X5kub01Xi5JXoadyUZrfgZocm2bQ1_224Fpo7sHvUxcvvwreB63a2XLOOk8UiJXnZpCQGQkR0FmcBqxrP1pQEgvAzpQxMYhHh0y0Jdr5hFYtDSDeRvEXNRmlaRvugZ6uGLebTxeEXRjy0n99_UPz7HhzPDr8ezNPuxoXU4clim6pJJbzkuXA16aSpCc8K672SE20RqqC5i8zVGQ_Ou1LWVUC4hohBOrpFyZeluA87zaoJD4EpFWTu8fgV6M-SrKyyledOVMJqF_I6gVf9hzfrVljDxAOJlqY1k0EzmWgmwxN4S7YZapIodnywOj81nY8ZywshAzZUSsKZUjsehJpkFjtR2kIk8JIsa8h10Xyu6jIQsMMkgmWmCJYQjyGASWBvVBNdzo2L-7lhOpffGJHTZe0IePMEng_F9CbR2Jqwuoh1hEaMJ8oEHrRTaRgSAUPi9CagR5NsNOZxSbM8i4LgedRA0tjw634-_u7Xvz_qo_-r_gx2P7-bmU_vFx8fww1O9yDTryi1Bzvb84vwBMHZ1j6N_vcLB0Awtg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relationship+between+albumin-globulin+ratio+and+prostate-specific+antigen%3A+a+cross-sectional+study+based+on+NHANES+2003%E2%80%932010&rft.jtitle=BMC+urology&rft.au=Gao%2C+Simeng&rft.au=Li%2C+Shaojie&rft.au=Wu%2C+Baofang&rft.au=Wang%2C+Jiayin&rft.date=2025-01-07&rft.pub=BioMed+Central&rft.eissn=1471-2490&rft.volume=25&rft_id=info:doi/10.1186%2Fs12894-024-01687-2&rft_id=info%3Apmid%2F39762822&rft.externalDocID=PMC11706081
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2490&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2490&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2490&client=summon